AMP Health vs Hers
AMP Health and Hers both sell semaglutide and tirzepatide; this is how their prices, coverage and records differ.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Hers
Best for: coverage in all 50 states, which most sellers will not confirm
Visit Hers →If you are choosing between AMP Health and Hers, price alone will not settle it. Both prescribe semaglutide and tirzepatide, so moving from one to the other would not change your drug. Hers leads our six-part score, 6.6 to 6.4. Both have drawn an FDA warning letter.
AMP Health vs Hers price
AMP Health and Hers start at the same figure, $199 a month, so the entry price does not separate them. Look at what each price covers and at the per-drug prices below.
Drug by drug: Semaglutide costs the same at both, $199 a month; tirzepatide is cheaper at Hers ($299 a month vs $309 a month).
Medications and formats
Both sell semaglutide and tirzepatide.
On format, AMP Health prices compounded injections, while Hers prices compounded injections and brand-name pens.
If you want the FDA-approved brand rather than a compounded version, Hers is the only one of the two with a brand-name price.
Where each one treats patients
AMP Health does not publish where it ships, and Hers lists 50 states.
Pricing
AMP Health
Plus $79/mo subscription
Plus $79/mo subscription
Plus $79/mo subscription
Hers
Brand Zepbound from $299/mo medication-only; requires Hers Weight Loss Membership ($149/mo)
What each price covers
Hers' price also covers the medication itself, which AMP Health does not claim.
AMP Health does not say what its price includes.
Hers is silent on shipping and lab work.
That matters most for the drug: unless AMP Health confirms otherwise, budget for medication on top of its listed price.
AMP Health
Inclusions not disclosed.
Hers
Covered by the monthly price
Medication
In the price
Clinician visits
Charged on top
Shipping
Not stated
Lab work
Not stated
Coaching
Charged on top
Where each one scores higher
Overall, Hers scores 6.6 and AMP Health 6.4 out of 10.
AMP Health is stronger on value (4.5 vs 3.0) and support (5.0 vs 3.0).
Hers is stronger on trust & safety (5.5 vs 3.5) and accessibility (10.0 vs 5.0).
Effectiveness and user experience are within half a point.
AMP Health
6.4/10
Hers
6.6/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
The FDA sent AMP Health a warning letter dated February 20, 2026 (letter 717992), and it is still open.
The FDA sent Hers a warning letter dated September 9, 2025 (letter 716825), and it is still open.
Features & Coverage
| Feature | AMP Health | Hers |
|---|---|---|
| Starting Price | $199/mo | $199/mo |
| Features | ✓4 features | 2 features |
| States Available | Not disclosed | 50 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | — | ✓ Yes |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | 1 letter | 1 letter |
About AMP Health
AMP Health sells compounded semaglutide, injectable and oral, from $199/mo and tirzepatide from $309/mo, on top of a $79/mo subscription fee. Brand Wegovy is listed but out of stock. There is a 30-day satisfaction guarantee.
Read our full AMP Health review →About Hers
Hers is the women-focused telehealth brand from Hims and Hers. It sells compounded semaglutide on a 6-month plan.
Read our full Hers review →Pros & Cons
AMP Health
What we like
- Semaglutide costs $199 a month, close to the $185 median for compounded semaglutide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
Watch-outs
- Tirzepatide costs $309 a month, 24% above the $250 median for compounded tirzepatide across the sellers we compare
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- The FDA has issued AMP Health a warning letter. Read what it alleges: a letter flags a problem but does not by itself rule a seller out
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Hers
What we like
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication
- Serves all 50 states
Watch-outs
- Not included in the monthly price: clinician visits, coaching
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- The FDA has issued Hers a warning letter. Read what it alleges: a letter flags a problem but does not by itself rule a seller out
- Its semaglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality
Our Verdict
Hers wins this one, 6.6 to 6.4, above all for coverage in all 50 states, which most sellers will not confirm. AMP Health fits better if an oral route if you will not self-inject is your priority.
Choose AMP Health if…
You want an oral route if you will not self-inject and an opening price near $199 a month.
Choose Hers if…
You want coverage in all 50 states, which most sellers will not confirm and an opening price near $199 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
ShedRx
Oral orforglipron alongside the injectables
From $149/mo
Get started →bmiMD
Starting below a standard dose, with microdose tiers
From $99/mo
Get started →RxSpan MD
Knowing which pharmacy fills the vial: it names Belmar Pharmacy
From $249/mo
Get started →AMP Health vs Hers: FAQ
Close alternatives to AMP Health and Hers
- AMP Health vs Hims
- AMP Health vs Curex
- AMP Health vs HumeCare+
- Hers vs Hims
- Hers vs Care Bare Rx
- Hers vs Concierge MD LA
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.